Respiratory physician Lutz Beckert considers chronic obstructive pulmonary disease management, including the prevention of COPD, the importance of smoking cessation and pulmonary rehabilitation, and the lifesaving potential of addressing treatable traits. He also discusses the logic of inhaler therapy, moving from single therapy to dual and triple therapy when indicated, as well as other aspects of management
What is the current state of the art in hepatitis B management?
What is the current state of the art in hepatitis B management?

This article reviews the current hepatitis B situation in New Zealand, including appropriate treatment
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.
1. Sarin SK, Kumar M, Lau GK, et al. Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update. Hepatol Int 2016;10(1):1–98.
2. Gane EJ, Charlton MR, Mohamed R, et al. Asian consensus recommendations on optimizing the diagnosis and initiation of treatment of hepatitis B virus infection in resource-limited settings. J Viral Hepat 2020;27(5):466–75.
3. El-Serag HB, Davila JA. Surveillance for hepatocellular carcinoma: in whom and how? Therap Adv Gastroenterol 2011;4(1):5–10.
4. Kao WY, Chao Y, Chang CC, et al. Prognosis of early-stage hepatocellular carcinoma: The clinical implications of substages of Barcelona Clinic Liver Cancer system based on a cohort of 1265 Patients. Medicine (Baltimore) 2015;94(43):e1929.
5. Huang CFS, Yu ML. The clinical utility of Elecsys GAAD score in the diagnosis of hepatocellular carcinoma. Asian Pacific Association for the Study of the Liver Single Topic Conference on Hepatocellular Carcinoma 2022.